Role of the sympathetic innervation on uterine electromyographic activity in nonpregnant ovariectomized sheep under estrogen supplementation.
The aims of the present study were to characterize the sympathetic innervation of the nonpregnant sheep uterus, to determine the catecholamine content in myometrium (MYO) and endometrium, and to study the effects of chemical sympathectomy (CHSPX) on uterine catecholamine content and on uterine electromyographic (EMG) activity recorded from the MYO and mesometrium (MESO) in the nonpregnant ovariectomized sheep. After synchronization of estrus, 9 nonpregnant sheep were anesthetized with halothane, ovariectomized, and fitted with vascular catheters and EMG electrodes. Estradiol-17 beta was administered intravascularly at a rate of 50 micrograms/24 h for 10 days. CHSPX was induced with 6-hydroxy dopamine (20 mg/kg). Uterine tissues were obtained for determination of catecholamine content by HPLC and for immunocytochemical staining using an antibody against tyrosine hydroxylase (TH). In nonpregnant ovariectomized sheep, TH immunostaining was present in nerve fibers located in endometrium and MYO. In all layers of the uterus, catecholamine fibers were found in the proximity of blood vessels as well as in defined regions of the parenchyma. Throughout the uterus, norepinephrine content and TH immunostaining were dramatically decreased after CHSPX. CHSPX decreased uterine short EMG event activity in both MYO and MESO. Contracture-type activity was not affected in MYO and was increased in MESO. We conclude that sympathetic innervation modulates the MYO and MESO EMG activity in nonpregnant ovariectomized sheep under estradiol supplementation, and that the removal of the sympathetic innervation induces a decrease in the spontaneous activity.
Massmann
G A
GA
Laboratory for Pregnancy and Newborn Research, New York State College of Veterinary Medicine, New York.
Figueroa
J P
JP
Hoffman
G
G
Nathanielsz
P W
PW
D000818:Animals; D015237:Dinoprost / Q000031:analogs & derivatives / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004576:Electromyography; D004717:Endometrium / Q000502:physiology; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D007150:Immunohistochemistry; D009215:Myometrium / Q000502:physiology; D009638:Norepinephrine / Q000378:metabolism; D010052:Ovariectomy; D016627:Oxidopamine; D012756:Sheep / Q000502:physiology*; D013563:Sympathectomy, Chemical; D013564:Sympathetic Nervous System / Q000502:physiology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D014599:Uterus / Q000294:innervation*
C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D004958:Estradiol; D016627:Oxidopamine; D015237:Dinoprost; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine; D009638:Norepinephrine